Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/d2/07/31/d20731e7-587a-2b82-d497-c39db83b5957/mza_10606593862519175967.png/600x600bb.jpg
JCO Precision Oncology Conversations
American Society of Clinical Oncology (ASCO)
57 episodes
6 days ago
JCO Precision Oncology Conversations is a monthly podcast featuring conversations with authors of clinically relevant and significant articles published in the JCO Precision Oncology journal. JCO Precision Oncology Conversations is hosted by the journal's social media editor, Dr. Abdul Rafeh Naqash.
Show more...
Medicine
Health & Fitness
RSS
All content for JCO Precision Oncology Conversations is the property of American Society of Clinical Oncology (ASCO) and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
JCO Precision Oncology Conversations is a monthly podcast featuring conversations with authors of clinically relevant and significant articles published in the JCO Precision Oncology journal. JCO Precision Oncology Conversations is hosted by the journal's social media editor, Dr. Abdul Rafeh Naqash.
Show more...
Medicine
Health & Fitness
Episodes (20/57)
JCO Precision Oncology Conversations
Somatic Mutations of Colorectal Cancer by Birth Cohort
3 weeks ago
7 minutes 33 seconds

JCO Precision Oncology Conversations
Areas of Uncertainty in Pancreatic Cancer Surveillance
1 month ago
16 minutes 57 seconds

JCO Precision Oncology Conversations
Lynch Syndrome Mortality in the Immunotherapy Era
1 month ago
26 minutes 49 seconds

JCO Precision Oncology Conversations
JCO PO Article Insights: A Retrospective Analysis to Identify ICI-Sensitive Populations
1 month ago
7 minutes 47 seconds

JCO Precision Oncology Conversations
Genomic Profile of Small Cell Bladder, Lung and Urothelial Cancer
1 month ago
17 minutes 3 seconds

JCO Precision Oncology Conversations
JCO PO Article Insights: MUC16 Directed BiTE Therapy in Epithelioid Sarcoma
2 months ago
5 minutes 42 seconds

JCO Precision Oncology Conversations
BRCA-Altered Uterine Sarcoma Treated with PARP Inhibitors
3 months ago
24 minutes 56 seconds

JCO Precision Oncology Conversations
JCO PO Article Insights: Prognostic Gene Expression Signature and MYC Expression in Osteosarcoma
3 months ago
4 minutes 26 seconds

JCO Precision Oncology Conversations
JCO PO Article Insights: Real-Time Monitoring in RCC with ctDNA
4 months ago
7 minutes 5 seconds

JCO Precision Oncology Conversations
A Position Paper on ctDNA Testing in Clinical Trials
5 months ago
23 minutes 15 seconds

JCO Precision Oncology Conversations
JCO PO Article Insights: TMB and Real-World ICI Outcomes in Melanoma
5 months ago
8 minutes 11 seconds

JCO Precision Oncology Conversations
Effectiveness and Cost-Effectiveness of Gene Panels in Melanoma
6 months ago
32 minutes 53 seconds

JCO Precision Oncology Conversations
JCO PO Article Insights: Exceptional Responders with Abexinostat and Pazopanib
6 months ago
6 minutes 44 seconds

JCO Precision Oncology Conversations
Prognostic Artificial Intelligence Scores and Outcomes in Nonmetastatic Prostate Cancer
7 months ago
20 minutes 49 seconds

JCO Precision Oncology Conversations
JCO PO Article Insights: Prognostic Artificial Intelligence Nonmetastatic Prostate Cancer
7 months ago
8 minutes 36 seconds

JCO Precision Oncology Conversations
JCO PO Article Insights: Therapy of Infantile Midline Low-Grade Gliomas
9 months ago
5 minutes 32 seconds

JCO Precision Oncology Conversations
Adagrasib Following Sotorasib-Related Hepatotoxicity
9 months ago
22 minutes

JCO Precision Oncology Conversations
JCO PO Article Insights: ctDNA as a Prognostic Biomarker in EGC
9 months ago
5 minutes 51 seconds

JCO Precision Oncology Conversations
Proteomics Predictor for Immunotherapy Benefit
10 months ago
21 minutes 21 seconds

JCO Precision Oncology Conversations
Transcriptome and ctDNA Associates with Pembrolizumab Benefit
11 months ago
23 minutes 19 seconds

JCO Precision Oncology Conversations
JCO Precision Oncology Conversations is a monthly podcast featuring conversations with authors of clinically relevant and significant articles published in the JCO Precision Oncology journal. JCO Precision Oncology Conversations is hosted by the journal's social media editor, Dr. Abdul Rafeh Naqash.